Literature DB >> 8419872

Presenting signs and symptoms of nasopharyngeal carcinoma.

J B Epstein1, C K Jones.   

Abstract

Pain in the head and neck may be due to multiple causes and difficult to localize. A definitive diagnosis can be difficult to make. The literature reports several cases of nasopharyngeal carcinoma presenting as temporomandibular disorders (TMD). The records of 52 patients with a diagnosis of nasopharyngeal carcinoma were reviewed to determine the frequency of symptoms that may be similar to TMD. In 13.5% of the patients common TMD signs and symptoms were present, such as clicking in the joint, pain while chewing, and limited opening. Of the patients reviewed, 44.2% described the location of their pain as headache, earache, or as jaw, midface, or neck pain. The most common description of pain was aching, dull, or pressing. Symptoms identified that may assist in differentiation of nasopharyngeal carcinoma from TMD include nosebleed, nasal stuffiness, altered hearing, and cervical lymph node enlargement. A patient with carcinoma of the nasopharynx may have symptoms that must be differentiated from TMD.

Entities:  

Mesh:

Year:  1993        PMID: 8419872     DOI: 10.1016/0030-4220(93)90402-p

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  6 in total

1.  Corticosteroid Therapy in Optic Neuropathy Secondary to Nasopharyngeal Carcinoma.

Authors:  Zulaikha Wahab; Evelyn Tai; Wan-Hazabbah Wan Hitam; Khairy Shamel Sonny Teo
Journal:  Cureus       Date:  2021-03-06

2.  Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy.

Authors:  Joel B Epstein; Diana J Wilkie; Dena J Fischer; Young-Ok Kim; Dana Villines
Journal:  Head Neck Oncol       Date:  2009-07-14

3.  Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma.

Authors:  Tanadech Dechaphunkul; Kowit Pruegsanusak; Duangjai Sangthawan; Patrapim Sunpaweravong
Journal:  Head Neck Oncol       Date:  2011-06-05

4.  Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts.

Authors:  Long-Hui Cao; Hui-Ting Li; Wen-Qian Lin; Hong-Ying Tan; Lan Xie; Zhong-Jian Zhong; Jian-Hua Zhou
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

5.  PEDF inhibits lymphatic metastasis of nasopharyngeal carcinoma as a new lymphangiogenesis inhibitor.

Authors:  Chuanghua Luo; Haofan Yin; Tianxiao Gao; Caiqi Ma; Junxi Liu; Ting Zhang; Zumin Xu; Xi Wang; Danrui Zhang; Weiwei Qi; Zhonghan Yang; Guoquan Gao; Xia Yang; Ti Zhou
Journal:  Cell Death Dis       Date:  2021-03-17       Impact factor: 8.469

6.  Multidisciplinary treatment approach in a patient with history of nasopharyngeal carcinoma.

Authors:  Atacan Yavuz; Omer Birkan Ağralı; Zeynep Lale Calışkan; Dilek Türkaydın; Atilla Sertgöz; Bahar Kuru; Başak Doğan
Journal:  Case Rep Dent       Date:  2014-01-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.